Form 4 for VCEL Vericel Corp
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $10.60 | +3,000 | 34.8K | +9% | +$31.8K |
| D | 2023-03-03 | 2023-03-01 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $0.00 | -3,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 3,000 | $10.60 | 34,795 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 3,000 | $0.00 | 0 | D | $10.60 · — to 2023-05-02 | 3,000 Common Stock | (F1) These options, representing the right to purchase a total of 3,000 shares, were originally granted on May 2, 2013, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company. |